140 related articles for article (PubMed ID: 37954860)
1. A2ML1 Inhibits Esophageal Squamous Cell Carcinoma Progression and Serves as a Novel Prognostic Biomarker.
Zhang X; Tang C; Lian J; Jiang Y
Can J Gastroenterol Hepatol; 2023; 2023():5557546. PubMed ID: 37954860
[TBL] [Abstract][Full Text] [Related]
2. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
[TBL] [Abstract][Full Text] [Related]
3. [Clinical significance of NS1-BP expression in esophageal squamous cell carcinoma].
Ren K; Qian D; Wang YW; Pang QS; Zhang WC; Yuan ZY; Wang P
Zhonghua Zhong Liu Za Zhi; 2018 Jan; 40(1):21-27. PubMed ID: 29365413
[No Abstract] [Full Text] [Related]
4. Macrophage inhibitory factor 1 acts as a potential biomarker in patients with esophageal squamous cell carcinoma and is a target for antibody-based therapy.
Wang XB; Jiang XR; Yu XY; Wang L; He S; Feng FY; Guo LP; Jiang W; Lu SH
Cancer Sci; 2014 Feb; 105(2):176-85. PubMed ID: 24383865
[TBL] [Abstract][Full Text] [Related]
5. Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma.
Yang ZT; Yeo SY; Yin YX; Lin ZH; Lee HM; Xuan YH; Cui Y; Kim SH
PLoS One; 2016; 11(1):e0145807. PubMed ID: 26731558
[TBL] [Abstract][Full Text] [Related]
6. CXCL12 expression promotes esophageal squamous cell carcinoma proliferation and worsens the prognosis.
Uchi Y; Takeuchi H; Matsuda S; Saikawa Y; Kawakubo H; Wada N; Takahashi T; Nakamura R; Fukuda K; Omori T; Kitagawa Y
BMC Cancer; 2016 Jul; 16():514. PubMed ID: 27439769
[TBL] [Abstract][Full Text] [Related]
7. DEPTOR suppresses the progression of esophageal squamous cell carcinoma and predicts poor prognosis.
Ji YM; Zhou XF; Zhang J; Zheng X; Li SB; Wei ZQ; Liu T; Cheng DL; Liu P; Song K; Tan T; Zhu H; Guo JL
Oncotarget; 2016 Mar; 7(12):14188-98. PubMed ID: 26893358
[TBL] [Abstract][Full Text] [Related]
8. MiR-455-3p acts as a prognostic marker and inhibits the proliferation and invasion of esophageal squamous cell carcinoma by targeting FAM83F.
Yang H; Wei YN; Zhou J; Hao TT; Liu XL
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3200-3206. PubMed ID: 28770965
[TBL] [Abstract][Full Text] [Related]
9. RNF113A promotes the proliferation, migration and invasion, and is associated with a poor prognosis of esophageal squamous cell carcinoma.
Wang L; Hou Z; Hasim A; Abuduerheman A; Zhang H; Niyaz M; Awut I; Upur H; Sheyhidin I
Int J Oncol; 2018 Mar; 52(3):861-871. PubMed ID: 29393393
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of OTX1 promotes tumorigenesis in patients with esophageal squamous cell carcinoma.
Chai J; Xu T; Yang Y; Yuan Y; Xu J; Liu J; Wang K; Lv Y; Chai J; Kang Y; Chen L; Qin J; Jia Q; Li M
Pathol Res Pract; 2022 Apr; 232():153841. PubMed ID: 35303522
[TBL] [Abstract][Full Text] [Related]
11. RACK1 predicts poor prognosis and regulates progression of esophageal squamous cell carcinoma through its epithelial-mesenchymal transition.
Wang N; Liu F; Cao F; Jia Y; Wang J; Ma W; Tan B; Wang K; Song Q; Cheng Y
Cancer Biol Ther; 2015; 16(4):528-40. PubMed ID: 25719728
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic inactivation of secreted frizzled-related protein 2 in esophageal squamous cell carcinoma.
Hao XW; Zhu ST; He YL; Li P; Wang YJ; Zhang ST
World J Gastroenterol; 2012 Feb; 18(6):532-40. PubMed ID: 22363119
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of miR-191 Predicts Poor Prognosis and Promotes Proliferation and Invasion in Esophageal Squamous Cell Carcinoma.
Gao X; Xie Z; Wang Z; Cheng K; Liang K; Song Z
Yonsei Med J; 2017 Nov; 58(6):1101-1110. PubMed ID: 29047233
[TBL] [Abstract][Full Text] [Related]
14. Intensive expression of UNC-51-like kinase 1 is a novel biomarker of poor prognosis in patients with esophageal squamous cell carcinoma.
Jiang S; Li Y; Zhu YH; Wu XQ; Tang J; Li Z; Feng GK; Deng R; Li DD; Luo RZ; Zhang MF; Qin W; Wang X; Jia WH; Zhu XF
Cancer Sci; 2011 Aug; 102(8):1568-75. PubMed ID: 21518141
[TBL] [Abstract][Full Text] [Related]
15. EIF3H promotes aggressiveness of esophageal squamous cell carcinoma by modulating Snail stability.
Guo X; Zhu R; Luo A; Zhou H; Ding F; Yang H; Liu Z
J Exp Clin Cancer Res; 2020 Aug; 39(1):175. PubMed ID: 32867821
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of JAB1 promotes malignant behavior and predicts poor prognosis in esophageal squamous cell carcinoma.
Shen Q; Shang B; Jiang B; Wang Y; Wang Z; Chen G
Thorac Cancer; 2020 Apr; 11(4):973-982. PubMed ID: 32064781
[TBL] [Abstract][Full Text] [Related]
17. Low expression of BEX1 predicts poor prognosis in patients with esophageal squamous cell cancer.
Geng HT; Cheng ZW; Cao RJ; Wang ZB; Xing SZ; Guo C; Wang F; Liu CM; Chen SS; Cheng YF
Oncol Rep; 2018 Nov; 40(5):2778-2787. PubMed ID: 30132532
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of F-box only protein 31 predicts poor prognosis and deregulates p38α- and JNK-mediated apoptosis in esophageal squamous cell carcinoma.
Liu J; Lv L; Gong J; Tan Y; Zhu Y; Dai Y; Pan X; Huen MSY; Li B; Tsao SW; Huo J; Cheung ALM
Int J Cancer; 2018 Jan; 142(1):145-155. PubMed ID: 28905993
[TBL] [Abstract][Full Text] [Related]
19. PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma.
Cui XB; Zhang SM; Xu YX; Dang HW; Liu CX; Wang LH; Yang L; Hu JM; Liang WH; Jiang JF; Li N; Li Y; Chen YZ; Li F
J Transl Med; 2016 May; 14(1):137. PubMed ID: 27188458
[TBL] [Abstract][Full Text] [Related]
20. Chitinase 3-like 1 secreted by peritumoral macrophages in esophageal squamous cell carcinoma is a favorable prognostic factor for survival.
Xing S; Zheng X; Zeng T; Zeng MS; Zhong Q; Cao YS; Pan KL; Wei C; Hou F; Liu WL
World J Gastroenterol; 2017 Nov; 23(43):7693-7704. PubMed ID: 29209110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
